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1. Introduction 
Over the last decade, surgeons have witnessed dramatic changes in the surgical 
management of differentiated thyroid carcinoma (DTC). This is not only a result of the 
introduction of new technologies in surgery but also a result of better understanding of the 
disease and its behavior. DTC accounts for over 90% of all follicular-cell derived thyroid 
malignancies and is the commonest primary endocrine-related malignancy. In our locality, 
its age-adjusted incidence has doubled over the last 20-25 years with a similar trend being 
observed elsewhere.(Hong Kong Cancer Registry, 2011) Despite this, the cancer-specific 
mortality remains low with an overall 10-year survival above 90%.(Lang et al., 2007a) 
However, recurrent or persistent disease after seemingly curative surgery poses a problem 
for both clinicians and patients.(Mazzaferri et al.,2001) Since surgery remains to play a 
pivotal role in the overall management of DTC, the primary aim of any new changes would 
be to further reduce and if possible, to prevent these recurrences or persistent diseases from 
occurring. Examples of some of these new changes would include: 1. the adoption of new, 
innovative surgical approaches (i.e. endoscopic, robot-assisted and trans-oral 
thyroidectomy) in surgical management of DTC in order to reduce the surgical morbidity, 
shorten hospital stay and enhance patient satisfaction; 2 the use of several surgical adjuncts 
such as new alternate energy sources (Harmonic scalpel (Ethicon), Sonosurg® (Olympus) 
and LigaSureTM (Valleylab), intraoperative nerve monitoring (IONM) and quick 
intraoperative parathyroid hormone assay (IOPTH) 3. the routine adoption of prophylactic 
central neck dissection (pCND) in DTC during total thyroidectomy. The aims of this review 
were to examine and evaluate these 3 broad subjects in an evidence-based matter and see if 
these changes could lead to better patient outcomes when compared to the conventional 
open thyroidectomy with or without the help of the surgical adjunct(s). 
2. Innovative surgical approaches 
2.1 Endoscopic thyroidectomy 
The application of endoscopic visualization to thyroid surgery has allowed surgeons to 
perform thyroidectomy through incisions far smaller and less visible than the conventional 
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Kocher’s incision – the so-called “less is more”. In general, these endoscopic techniques 
attempt to minimize the extent of dissection, improve cosmesis, reduce post-operative pain, 
shorten hospital stay and hasten postoperative recovery. Michel Gagner was the first 
surgeon to report the feasibility of endoscopic technique to neck surgery.(Gagner, 1996) He 
reported a totally endoscopic subtotal parathyroidectomy in a 37 year old man suffering 
from familial hyperparathyroidism. (Gagner, 1996) Although the endoscopic procedure took 
over 5 hours, it demonstrated the technical feasibility and safety. Over the turn of the last 
century, an increasing number of different endoscopic techniques have been described and 
may be categorized into namely cervical or direct and extracervical or indirect 
approaches.(Lang, 2010a) The former is considered as truly minimally invasive since the 
skin incisions are small in the neck with direct access to the thyroid gland. On the other 
hand, the extracervical approach is considered as an endoscopic instead of minimally 
invasive approach because incisions are made distant from the neck and so the approach 
requires more extensive tissue dissections.(Henry, 2008) However, despite its invasiveness, 
it offers superior early cosmetic outcome because potentially unsightly scars can be hidden 
and so patients remains “scarless in the neck”. This approach has been adopted more often 
in Asian countries where remaining “scarless in the neck” after thyroidectomy is a priority 
for a select group of patients.(Lang & Lo, 2010b) 
2.1.1 Cervical / direct approaches  
These approaches include the endoscopic lateral cervical approach and the minimally 
invasive video-assisted thyroidectomy (MIVAT). In the endoscopic lateral cervical 
approach, two 2.5mm and one 10mm trocars are inserted under direct vision along the 
anterior border of the sternocleidomastoid muscle on the side of resection. Using endoscopic 
instruments, the dissection starts from the lateral aspect of the thyroid gland and moves 
medially with identification of the recurrent laryngeal nerve (RLN), parathyroid glands and 
skeletonisation of the superior and inferior thyroid vessels.(Palazzo et al., 2006) Excellent 
visualization of RLN and parathyroid glands is possible with magnification by the 
endoscope. However, this technique is limited to unilateral thyroid resection and its 
application in thyroid cancer surgery is restricted to sub-centimeter papillary thyroid 
carcinoma (PTC) detected by high-resolution ultrasound machines. In contrast, the MIVAT 
would be preferred if bilateral thyroid resection is necessary because the incision is made in 
the midline instead of the lateral aspect of the neck. A 2cm incision is made in the middle of 
the neck about 2cm above the sternal notch. Blunt dissection is then carried out to separate 
the strap muscle from underlying thyroid lobe. A 5mm 30 degree endoscope is placed inside 
the 1.5cm wound for lighting and visualization. The procedure is performed under 
endoscopic view with the operating space maintained by external retraction. This technique 
was first applied for selected benign thyroid conditions in 2000.(Miccoli et al., 2000) 
However, with improvement in techniques, MIVAT has become increasingly adopted for 
low- to intermediate risk DTC.(Miccoli et al., 2009) MIVAT was shown to achieve similar 
completeness of resection and 5-year survival outcomes as those with low- and intermediate 
risk PTC undergoing conventional thyroidectomy.(Miccoli et al., 2009; Miccoli et al., 2002; 
Lombardi et al.,2007a) In addition, it has been shown that a concomitant pCND is 
technically feasible in MIVAT during initial total thyroidectomy.(Bellantone et al., 2002) 
Also for patients with low risk PTC with concomitant lateral lymph node metastases, a 
minimally invasive video-assisted functional lateral neck dissection through a small neck 
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incision is also technically possible.(Lombardi et al,, 2007b) A recent randomized trial 
comparing conventional thyroidectomy with MIVAT found that the latter was associated 
with a lower risk of wound infection.(5.3% vs 0.0%, p<0.05)(Dionigi et al.,2011) 
2.1.2 Extra-cervical / indirect endoscopic approaches 
Unlike the cervical approaches, these approaches involve making incisions either in the 
chest, breast and/or axilla to hide the scars with clothing.(Lang, 2010a) Ikede et al. first 
described these approaches by placing three ports in the axilla with low-pressure gas 
insufflation for maintaining the operating space. Although cosmetic results were excellent, 
the procedure was technically demanding and time consuming because of unintentional 
easy gas leakage and frequent interference of the 3 operating surgical instruments in the 
small available space in the axilla.(Ikeda et al., 2003) Chung et al. modified this technique by 
making this approach gasless with the space maintained by a specially designed skin-lifting 
external retractor.(Kang et al.,2009a) In this approach, the procedure began with a 4 to 5cm 
incision in the axilla and then a subcutaneous space was created from the axilla to the 
thyroid gland. To avoid the problem of interference of instruments, an additional 5mm port 
was inserted in the chest area for medial retraction of the thyroid gland. Chung et al. 
recently reported their experience with this approach after performing 581 cases.(Kang et al., 
2009a) Among these patients, 410 patients had low-risk PTC. In their series, concomitant 
pCND was performed and the rate of lymph node metastasis was 27.3%.(Kang et al., 2009a) 
To further increase the degree of angulations and freedom of interference between 
instruments, a combined axillo-breast approach was developed utilizing 2 circumareolar 
trocars in the breast and a single trocar in the ipsilateral axilla. This approach was later 
modified by using bilateral axillary ports to allow better exposure to both sides of the 
thyroid compartment. This approach is now known as the bilateral axillo-breast approach 
(BABA). Despite the extensive tissue dissection, when compared with the conventional open 
approach, BABA has been shown to have similar results in terms of transient hypocalcemia, 
bleeding, permanent RLN paralysis and length of hospital stay.(Chung et al., 2007) More 
recently, a Korean group tried to eliminate wounds around the chest or breast areas all 
together by making incisions in the axilla and post-auricular areas instead. They reported a 
small series of 10 patients using this approach and 7 underwent bilateral thyroid resection 
for low-risk PTC. They demonstrated the feasibility of this technique of scarless (in the neck) 
thyroid surgery.(Lee et al., 2009a) 
2.2 Robotic-assisted thyroidectomy 
The application and feasibility of the endoscopic approach was given a further boost with 
the availability of various robotic systems such as the da Vinci system (Intuitive Surgical, 
Sunnyvale, California). Unlike other cancers such as prostate cancer, the initial enthusiasm 
of using the robot in thyroid cancers was not great because of its relatively high cost, 
bulkiness of the robotic arm and long operating time. However, since the publication of two 
large surgical series demonstrating the feasibility and safety of robotic assisted 
thyroidectomy in DTC, an increasing number of specialized surgical centers worldwide are 
beginning to accept and perform this procedure. The theoretical advantages of using the 
robot over the endoscopic approach include the three-dimensional view offer to the 
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operating surgeon, the flexible robotic instruments with seven degree of freedom and 900 
articulation, the increased tactile sensation and the ability to filter any hand tremors.(Kang 
et al., 2009b) Kang et al. recently reported their experience of 200 robot-assisted total 
thyroidectomy using the gasless trans-axillary approach for low-risk PTC with concomitant 
pCND and found excellent short-term results in terms of postoperative pain and patients’ 
satisfaction.(Kang et al., 2009c) This was followed briefly by another report of 338 benign 
and malignant cases using the same trans-axillary.(Kang et al., 2009d) To date, this group 
has performed over 1000 cases. A separate Korean group also reported similar results using 
the da Vinci robot via the BABA technique.(Lee et al., 2009b) Although both techniques have 
been demonstrated to be feasible and safe, they have been limited to a few high-volume 
specialized centers. The surgeons performing these operations have had years of operating 
experience with the endoscopic approach and so the learning curve for a novel, non-
endoscopic thyroid surgeon or someone who predominantly perform open thyroid 
procedures, remains undefined but is likely to be longer than one might think. Furthermore, 
better comparative studies such as a randomized controlled trial between robotic-assisted 
and endoscopic thyroidectomy are needed in order to better assess the added patient 
outcome benefits over the latter approach. 
2.3 Endoscopic vs robotic-assisted thyroidectomy via the transaxillary route 
Since both approaches actually utilize the same surgical approach (i.e. the transaxillary 
route), an obvious question would be whether using the robot would have added benefits 
over the conventional endoscopic operation, perhaps in terms of operating time, 
complication rate or number of assistants required.(Lang et al., 2011a) Lang et al. first 
reported a small series of patients who underwent the endoscopic (i.e. without the robot) 
and the robot-assisted thyroidectomy for mostly benign cases and compared their outcomes. 
They found that the robotic group was associated with an increased total procedure time 
and resulted in higher pain score on day 0 than the endoscopic group but the robot was able 
to eliminate the need of an extra surgical assistant at the time of operation.(Lang & Chow, 
2011b) Lee et al. reported a larger series of patients with mostly papillary thyroid 
microcarcinomas. In their series, the robotic group was associated with shorter operating 
time, more lymph nodes retrieval and shorter learning curve.(J.Lee, 2011) This was followed 
by another larger series reported by the same group comparing the two approaches. In this 
study, they confirmed that the robot assisted thyroidectomy was superior to endoscopic and 
postulated that the reason for this superiority was because of the limitations of the 
conventional endoscopic instruments. (S.Lee, 2011) These contradictory findings could be 
explained by the fact that the first series comprised mainly benign nodular cases and so no 
pCND was necessary whereas in the latter two series, pCND was performed at the time of 
the thyroidectomy. Therefore, perhaps more complex surgical procedures might benefit 
from the robot whereas a straightforward operation such as a hemithyroidectomy or total 
thyroidectomy, the robot might not be any extra benefits.(Lang et al., 2011a) 
2.4 Transoral thyroidectomy 
This remains one of the most contentious surgical approaches and one of the most extreme 
examples of preferring “scarless in the neck” in thyroidectomy. The concept began in 2008 
when Witzel et al. presented an experimental “natural orifice surgery” or NOS approach for 
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thyroidectomy.(Witzel et al.,2008) To minimize the surgical trauma, they presented a 
transoral access to the thyroid gland using a single port access via an axilloscope. Following 
this, Wilhelm et al. reported the first 8 cases of transoral thyroidectomy in humans. The 
incisions were made in the vestibule of the mouth and conventional endoscopic instruments 
were inserted in the subplatysmal layer, anterior to the thyroid cartilage. However, 
parathesia of the mental nerve was reported in the first six cases and two unilateral RLN 
palsies were also noted in two of eight cases. Also there was one patient who developed a 
minor infection at the vestibular incision 4 weeks after surgery.(Wilhelm & Metzig, 2011) 
Therefore, at this moment, one could say that this approach is technically feasible but 
remains experimental and is associated with a higher rate of complications than the 
conventional open approach.  
3. Use of surgical adjuncts 
3.1 IONM  
RLN injury is a leading cause of litigation in thyroid surgery.(Ready & Barnes, 1994) To 
those with this injury, it not only affects the voice quality but also diminishes the overall 
quality of life because of communication, social and work-related problems.(Smith et al., 
1998) Routine RLN identification is considered the standard of care in thyroid surgery. 
However, with the availability of IONM, the questions are whether this new piece of 
technology could further reduce the risk of iatrogenic RLN injury in thyroid surgery or 
thyroid cancer surgery in particular.  
Although IONM has been around for over 3 decades, its widespread usage in the surgical 
practice only dates back 5-10 years. There has been an increased in interest on applying this 
technique for thyroid surgery because of the introduction of new and user-friendly devices 
from technological advance.(Chan & Lo, 2006a) Currently, there are two types of IONM 
systems, namely those with electromyographic (EMG) documentation and those without 
EMG documentation. The former involves RLN stimulation with registration of the elicited 
laryngeal muscle activity through endoscopic insertion of electrodes into the vocal fold or 
with the use of endotracheal surface electrodes. The latter utilizes RLN stimulation with 
observation of posterior cricoarythenoid muscle contraction or palpation or intraoperative 
inspection of vocal cord function.(Dralle et al., 2008; Dralle et al., 2004) To date, there is no 
consensus on which is the best system and the choice depends on the availability of which 
system in your institution and the operator familiarity or experience. Regardless of which 
systems, there are potential flaws and pitfalls. In general, the positive predictive value (PPV) 
is proportionally low with this technology. That means that when a nerve has no signal 
during stimulation, it does not mean that it is injured. In fact, in our experience, the PPV was 
only 15% in low-risk thyroid surgery i.e. approximately only 1 out of 9 RLNs with no signals 
had an actual injury. This might be due to some technical errors such as detachment or 
displacement of electrodes or poor contact of the probe with the nerve due to inadequate 
exposure.(Chan & Lo, 2006) Perhaps, direct vagal stimulation could possibly reduce some of 
these errors but need more unnecessary dissection. Even more intriguing is the fact that this 
technique is also associated with false negative results, albeit rarely. In our experience, 
among 271 nerves at risk, 15 (5.5%) ended with RLN palsy but of these, 7 still had a positive 
IONM signals. Therefore, it seems that IONM might not be able to detect “sub-lethal” injury 
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to RLN. It is possible that the action potential could be propagated along the neural 
pathway, as detected by the IONM, but not to the extent of initiating laryngeal muscle 
contraction during the postoperative period.(Chan, 2006a,2006b) Fortunately, all these 
injuries would invariably recover.  
On the other hand, although the objective of the use of this device is to avoid RLN injury 
during thyroid surgery, the evidence of supporting its routine use has been weak. The first 
multicenter study including 29,998 RLNs at risk confirmed that the incidence of RLN palsy 
was not significantly reduced by the additional use of IONM when routine RLN 
identification was performed.(Dralle et al., 2004) There were more than 20 publications 
addressing this issue but majority of these studies were heterogeneous in terms of patients’ 
characteristics (such as primary operations vs reoperations or benign vs malignant goiters), 
IONM techniques and the extent of resection (i.e. total vs subtotal lobectomy). A recent 
literature review could not definitely draw confirm conclusions or evidence on the 
effectiveness of IONM in reducing RLN injury in thyroid surgery.(Dralle et al., 2008) 
Furthermore, most studies were either case-series with no control group or retrospective 
studies with inadequate statistical power to demonstrate a difference between those with or 
without using IONM. In fact, a randomized study utilizing approximately 7,000 patients in 
each arm of patients undergoing thyroidectomy with or without IONM will be required to 
have adequate statistical power to show a difference in outcome with reference to RLN 
paralysis.(Dralle et al., 2004; Dralle et al., 2008) Interestingly though, the first prospective 
randomized study comparing IONM with routine RLN visualization only was recently 
published.(Barczynski et al., 2009) In this study, approximately 500 patients were 
randomized into each arm. The number of patients recruited in each arm was based on the 
principle of detecting a 2% difference in the incidence of transient RLN injury with a 90% 
probability at p<0.05. This study did demonstrate a statistically significant difference in 
reducing transient RLN injury when IONM was adopted in comparison with RLN 
visualization only. However, as expected, the rate of permanent RLN injury was similar in 
the two study arms because of inadequate statistical power. Nevertheless, despite the 
inadequate power of most published IONM studies, there seemed to be a trend toward 
improved RLN protection with the use of this new technology.(Dralle et al. 2008) In 
addition, the IONM may be of potential benefit for “difficult” cases such as reoperative 
thyroidectomy, locally advanced thyroid cancers or central neck dissection for cancer 
recurrence. Perhaps, for the relatively inexperienced surgeons, the IONM might reduce the 
incidence of RLN injury in difficult cases. 
3.2 IOPTH (intraoperative parathyroid hormone) for predicting post-thyroidectomy 
hypoparathyroidism 
Hypoparathyroidism is a common complication after bilateral thyroid resections or total 
thyroidectomy. Up to 30% of patients after total thyroidectomy develop temporary 
hypoparathyroidism.(Pattou et al.,1998) There are many identifiable risk factors leading to 
postoperative hypoparathyroidism including thyroidectomy for thyrotoxicosis and thyroid 
cancer, thyroid reoperations, reduced stores of vitamin D, increased extent of thyroid 
resection and need of concomitant pCND.(McHenry et al., 1994;Abboud et al. 2002) Patients 
undergoing thyroidectomy for thyroid cancer are particularly prone to hypoparathyroidism 
because they often need a more complete thyroid resection together with neck dissection. In 
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fact, total thyroidectomy and pCND is increasingly being performed for DTC to achieve 
lower recurrences, better disease-free survival and enhanced postoperative 
athyroglobulinemia.(Roh et al. 2007; Lang et al., 2011c) However, it has been shown that up 
to 60% of patients after pCND could develop transient hypocalcemia secondary to the 
frequent occurrence of unintentional or incidental parathyroidectomy.(Pereira et al.,2005) 
Therefore, in the presence of such a high incidence of postoperative hypoparathyroidism, 
the need of routine postoperative inpatient calcium monitoring remains questionable after 
thyroid cancer surgery while the early routine administration of oral calcium and/or 
vitamin D supplements seems to be relevant and can facilitate the early discharge from 
hospital shortly after surgery without developing unpleasant hypocalcemic 
symptoms.(Grodski & Serpell,2008) In fact, a recent randomized study supported this 
strategy because routine administration of oral calcium was shown to markedly reduce the 
severity and symptoms of hypocalcemia.(Roh et al.,2009) However, the adoption of this 
strategy could lead to over-treatment in patients who do not have hypocalcaemia leading to 
rebound hypercalcemia and increased medication costs. On the other hand, this strategy 
might lead to inadequate treatment in patients with severe symptomatic hypocalcaemia as 
oral calcium alone may not fully correct the hypocalcemia and so vitamin D supplements is 
indicated in such situation.(Lo,2003) 
On the other hand, in-patient serial close monitoring of serum calcium is recommended 
after total thyroidectomy because most symptomatic hypocalcemia occurs around 24-28 
hours after surgery.(Pfleiderer et al.,2009) A 24-hour or longer hospital stay is invariably 
required. Therefore, efforts are made to shorten hospital stays, decrease biochemical blood 
tests and reduce hospital costs by adopting other strategies to achieve early prediction of 
post-thyroidectomy hypocalcemia. With the availability of IOPTH and wide application in 
patients undergoing minimally invasive parathyroidectomy to predict postoperative cure, 
this new surgical adjunct has been applied to thyroid surgery to monitor parathyroid 
function and to predict the occurrence of postoperative normocalcaemia or hypocalcaemia. 
In our early prospective study of using IOPTH in predicting hypocalcemia in 100 
consecutive patients (including 33 patients with DTC) who underwent either total or 
completion thyroidectomy, we found that a normal level of IOPTH at 10mins or a level less 
than 75% decline in IOPTH at 10 mins after excision of thyroid gland accurately identified 
normocalcemia.(Lo et al.,2002) It was suggested that intraoperative or early postoperative 
parathyroid hormone assay might be a sensitive tool to confirm postoperative 
normocalcaemia and identify patients at-risk of developing postoperative hypocalcaemia. 
Since then, up to 30 different investigators have published their results of using various 
different IOPTH assays in predicting hypocalcemia after total thyroidectomy. The IOPTH 
levels and their rate of decline at various time points after surgery could be utilized for 
prediction of postoperative hypocalcaemia with variable sensitivity, specificity and 
accuracy.(Lombardi et al.,2004,2006) However, based on two evidence-based reviews, it was 
recommended that the IOPTH level within a few hours after thyroid surgery could 
accurately predict postoperative normocalcaemia and identify patients at-risk of developing 
hypocalcemia, particularly severe, symptomatic hypocalcemia.(Grodski & Serpell, 2008; 
Noordzij et al.,2007) It was suggested that patients could be stratified into high or low risk 
groups and PTH should be measured at 1-6 hrs after operation in comparison to 
preoperative PTH. A <  or > 65% decline at 6 hours after operation should allow early 
discharge or facilitate the decision of early calcium supplement. On the other hand, a 
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strategy of 2 cut-off points should be considered with a high accuracy. A <50% decline 
within few hours after surgery allowed early discharge while a >90% decline necessitated 
early calcium supplement because of the accuracy in predicting normocalcaemia and 
hypocalcaemia respectively.(Noordzij et al.,2007) For those patients with 50-90% decline, 
either serial calcium monitoring or routine treatment should be considered. In the AES 
guideline, one single serum PTH measurement is recommended at 4 hrs after 
operation.(AES group, 2007) A normal PTH can predict normocalcaemia and patients can be 
discharged early with 7% subsequently developing mild hypocalcaemia. For patients with 
undetectable PTH level, oral calcium and vitamin D analogue should be administered early 
to avoid symptomatic hypocalcaemia. Intermediate or subnormal PTH level is a less 
accurate predictor of hypocalcaemia. In that case, oral calcium should commence or patients 
should be monitored with serial calcium levels for the need of calcium and/or vitamin D 
analogue.(AES group,2007) Therefore, PTH assay can now be considered as a perioperative 
adjunct to predict normocalcaemia or hypocalcaemia with reasonable accuracy. It can 
facilitate early discharge, avoid routine calcium replacement, facilitate early calcium 
replacement to avoid symptomatic hypocalcaemia and decrease overall cost as well as 
increase patients’ satisfaction. However, probably in the community hospital setting where 
IOPTH may not be available, the least expensive alternative option for same day discharge 
is routine postoperative oral calcium +/- vitamin D supplementation. 
3.3 Alternate energy source for intraoperative hemostasis in thyroidectomy 
In addition to scalpels and ligatures, alternate energy such as electric (e.g. ligasure) and 
ultrasonic (e.g. harmonic scalpel (Ethicon) and Sonosurg®) have been used for cutting and 
hemostasis in surgery. An unique feature of thyroidectomy is that thyroid gland has one of 
the richest blood supplies among the organs, with numerous blood vessels and plexuses 
entering the parenchyma. These vessels are usually controlled with ligatures (or clamp and 
tie) but the ligation and division of these vessels is time consuming and so perhaps the use 
of these alternate energy sources may reduce the actual operating time and cost. Essentially 
both ligasure or harmonic scalpel were consistently shown to shorten the total operating 
time by approximately 15-30% but in terms of complication rates, there was no statistically 
difference when compared to the conventional clamp and tie technique. Similarly, a recent 
meta-analysis which included 7 randomized trials comparing harmonic scalpel with 
conventional clamp and tie technique found that there was a weighed mean reduction of 
operative time of 18.74 minutes (95% CI: 10.52 – 28.97 minutes, p<0.001) but there was no 
statistical difference in complication rates.(Cirocchi et al., 2010) 
 
First author 
(year) 
No. of 
patients
Design 
Two 
arms 
Type of 
surgery
Type of 
thyroid 
pathology 
Conclusions 
Voutilainen 
(2000) 
36 RCT CT vs HS HT/TT 
Benign and 
malignant 
HS:  operating 
time; short learning 
curve 
Siperstein 
(2002) 
171 RS CT vs HS HT/TT 
Benign and 
malignant 
HS:  operative time 
by 30mins in HT and 
TT 
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First author 
(year) 
No. of 
patients
Design 
Two 
arms 
Type of 
surgery
Type of 
thyroid 
pathology 
Conclusions 
Ortega (2004) 200 RCT CT vs HS HT/TT Benign 
HS: 15-20% reduction 
in operating time, 
less costs 
Petrakis 
(2004) 
517 RS CT vs LS TT Benign 
LS:  operating time, 
less RLN injury, less 
blood loss, less 
hypocalcemia 
Kiriakopoulos 
(2004) 
80 PS CT vs LS TT 
Benign and 
malignant 
Similar operating 
time and blood loss 
Kirdak 
(2005) 
58 PS CT vs HS HT/TT 
Benign and 
malignant 
HS:  operating time 
only 
Cordon 
(2005) 
60 RCT CT vs HS HT/TT 
Benign and 
malignant 
HS:  operating time 
only 
Franko 
(2006) 
155 RS CT vs LS HT/TT 
Benign and 
malignant 
LS:  operating time, 
less blood loss, less 
hypocalcemia 
Lepner 
(2007) 
403 RS CT vs LS HT/TT Not specified
LS:  operating  
time, less 
hypocalcemia 
Sartori (2008) 150 RCT 
CT vs 
LS/HS 
HT/TT 
Benign and 
malignant 
HS:  operating 
time, more 
hypocalcemia 
Pons  
(2009) 
60 RCT 
CT vs 
LS/HS 
TT Not specified
HS:  operating 
time, less pain  
and cost 
Cirocchi 
(2010) 
608 
MA  
(7 RCTs)
CT vs HS TT 
Benign and 
malignant 
HS:  operating 
time, less cost  
but similar 
complication rates 
Zarebczan 
(2011) 
231 RS HS vs LS HT/TT 
Benign and 
malignant 
HS:  operating time 
but complications 
were similar 
Rahbari 
(2011) 
90 RCT HS vs LS HT/TT 
Benign and 
malignant 
No difference  
in operating  
time, cost or  
complications 
Abbreviations: RCT = randomized controlled trial; PS = prospective study; RS = retrospective study; 
MA = meta-analysis; CT = conventional technique; HS = harmonic scalpel; LS = ligasure; HT = 
hemithyroidectomy; TT = total thyroidectomy 
Table 1. shows a summary of the trials and their conclusions comparing different hemostatic 
techniques in thyroidectomy. 
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4. The role of pCND in DTC 
The role of pCND in DTC remains one of the most discussed surgical subjects in recent few 
years. To date, there is little good evidence to show that pCND improves cancer-specific 
survivals or reduces cancer-specific mortality in DTC. 
 
First author 
/year of 
publication 
Number of patients Follow up 
duration 
(months) 
Cancer-specific mortality 
p-value CND+ 
group 
CND- group
CND+ 
group 
CND- group 
Tisell/ 
1996 
P/T - 195 199;167 
156 months 
(median) 
8.4% - 11.1% 1.6% 
Not 
reported 
Sywak/ 
2006 
P - 56, A 391 
CND-: 70 
months 
CND+: 25 
months 
(median) 
0% 0% 
Not 
statistically 
significant 
Roh/2007 
P - 40, B 
T - 42 (26/42 
with lateral 
neck 
dissection)
73 
52 months 
(mean) 
0% 0% 
Not 
statistically 
significant 
Abbreviations: CND-: thyroidectomy alone, CND+: thyroidectomy plus central neck dissection; P: 
prophylactic, T: therapeutic; A: unilateral, B: bilateral 
Table 2. A literature summary of studies which specifically evaluated cancer-specific 
mortality between thyroidectomy alone or thyroidectomy with pCND. 
To date, the strongest evidence supporting the role of pCND in DTC came from an earlier 
study carried out by a Swedish group. Tisell et al. evaluated 175 patients who underwent 
thyroidectomy with CND and compared with contemporaneous controls from other two 
studies of Scandinavian population conducted on patients in Norway and Finland.(Tisell et 
al. 1996;Kukkonen et al. 1990; Salvesen et al. 1992) They showed that patients who 
underwent thyroidectomy with pCND had a higher survival rate (1.6% vs. 8.4-11.1%). 
However, these studies were criticized for including patients with gross lymph node 
involvement requiring therapeutic neck dissections. (Tisell et al.,1996; Kukkonen et al.,1990; 
Salvesen et al.,1992)   
Another important outcome parameter or survival surrogate is disease recurrence or 
disease-free survival. 
However, it is difficult to interpret their results as there were great variations in terms of 
indication (therapeutic or prophylactic), extent (unilateral or bilateral) and duration of 
follow up among different studies. The majority of studies did not show any significant 
differences. Moo et al. reported a decrease in recurrence rate in patients who underwent 
bilateral pCND (4.4% vs 16.7% p=0.13).(Moo et al.,2010) Zungia et al. analyzed a cohort of 
266 patients with 6.3 years mean follow up and reported the 5-year disease-free survival was 
comparable (88.2% vs. 85.6%; p= 0.72).(Zuniga et al.,2009) Interestingly, a recent meta-
analysis comprising 5 retrospective comparative studies (n=1264) found that there was an 
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insignificant trend toward lower overall recurrence rate in the group who underwent either 
unilateral or bilateral pCND when compared to those who had total thyroidectomy only 
(2.02% vs 3.92%,odds ratio (OR) = 1.05, 95% confidence interval (CI) = 0.48 – 2.31).(Zetoune 
et al.,2010) Their subgroup analysis revealed no decrease in central (1.86% vs. 1.68%, OR 
1.31, 95% CI = 0.44-3.91) or lateral compartment recurrence (3.73% vs. 3.79%, OR 1.21, 95% 
CI = 0.52 -2.75).(Zetoune et al.,2010) Therefore, based on these findings, there might be a 
potential benefit of lower recurrence in those who underwent either unilateral or bilateral 
pCND, although larger-scale prospective studies are required to confirm this. 
 
Study 
design 
First author 
/ year of 
publication
Number of 
patients Follow up 
(mean) 
Overall recurrence p-value 
CND+ 
group 
CND- 
group 
CND+ 
group 
CND- 
group 
 
Retro-
spective 
Gemsenjager
/ 2003 
P - 29 88 8.1 years 3.4% 2.3% 
Not 
mentioned 
Retro-
spective 
Wada / 2003 P - 235 155 53 months 0.4% 0.6% 
Not 
significant 
Retro-
spective 
Sywak / 
2006 
P-56, A 391 
CND-: 
70 months
CND+: 
24.5 
months 
(median) 
3.6% 5.6% 
Not 
mentioned 
Retro-
spective 
Roh / 2007
P–40, B
T – 42, B
73 52 months
P - 0% 
T - 1.2%
4.0% 
Not 
mentioned 
Retro-
spective 
Zungia / 
2009 
P-136,B 130 6.9 years 
5yr DFS -
88.2% 
5yr DFS 
- 85.6%
0.72 
Retro-
spective 
Costa / 2009 P-126,B 118 
CND-: 
64 months
CND+: 
47 months
6.3% 7.7% 0.83 
Retro-
spective 
Moo / 2010 P-45, B 36 3.1 years 4.4% 16.7% 0.13 
Meta-
analysis 
Zetoune / 
2010 
P – 396, 
A/B 
868  2.0% 3.9% NS 
Retro-
spective 
Lang / 
2011c 
P – 82, A 103 26 months 3.7% 2.9% 1.0 
Table 3. A literature summary of studies which evaluated recurrence rates between 
thyroidectomy alone or thyroidectomy with pCND. 
Serum Tg level is useful in detecting persistent or recurrent DTC after thyroidectomy and 
RAI ablation.(Hay et al.,2002) A detectable post-surgical Tg level is associated with risk of 
recurrence and so it may be applied as an surrogate marker of outcome in studying 
prognosis of DTC.(Cooper et al.,2009;Leboulleuz et al.,2005) Sywak et al. examined 447 
patients with clinically node-negative papillary thyroid carcinoma, while 56 patients 
underwent thyroidectomy and pCND.(Sywak et al.,2006) Though there was no significant 
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difference in recurrence or survival after a short median follow up (thyroidectomy plus 
pCND vs. thyroidectomy alone: 25 vs. 70 months), they showed that there was a 
significantly lower level of stimulated Tg at 6 months after RAI ablation (mean: 0.41 vs. 9.3, 
p=0.02), and higher proportion of athyroglobulinemia (72% vs. 43%; p< 0.001).(Sywak et 
al.,2006) In contrast, Hughes et al. found that there was no difference in post-ablation 
median stimulated Tg level or rate of athyroglobulinemia between patients undergoing 
thyroidectomy with or without bilateral pCND.(Hughes et al.,2010) However, in their 
subgroup analysis of patient undergoing pCND, they demonstrated that pre-ablation Tg 
level was significantly higher in node positive patient these patients achieved a comparable 
rate of post-ablation athyroglobulinemia after a higher dose of RAI.(Hughes et al.,2010) 
More recently, Lang et al. retrospectively analyzed 185 patients with PTC and of these, 82 
(44.3%) patients had an unilateral pCND together with a total thyroidectomy (CND+ 
group).(Lang et al.,2011c) They found that the CND+ group had a significantly lower 
median pre-ablation stimulated Tg level (<0.5ug/L vs. 6.7ug/L,p<0.001) and achieved a 
higher rate of pre-ablation athyroglobulinemia (51.2% vs. 22.3%,p=0.024) than those who 
underwent a total thyroidectomy only but these differences were not observed 6 months 
after ablation. They also found that pCND was the only independent factor for pre-ablation 
athyroglobulinemia.(Lang et al.,2011c) In their experience, most of the residual microscopic 
disease, presumably not removed by the initial pCND, was still able to be ablated by RAI 
ablation and so the group without pCND achieved similar stimulated Tg levels and similar 
rate of athyroglobulinemia 6 months after ablation.(Lang et al.,2011c) The authors concluded 
that although performing pCND in total thyroidectomy may offer a more complete initial 
tumor resection than total thyroidectomy alone by minimizing any residual microscopic 
disease, such difference becomes less noticeable 6 months after RAI ablation.(Lang et 
al.,2011c) The other advantage of performing pCND is the fact that the status of central 
lymph nodes or pN1a is better known and so more accurate staging is possible.(Lang et 
al.,2007b) 
Increased patient morbidity is one of the major concerns. Increased risk of transient 
hypoparathyroidism has been consistently shown in many studies.(Sywak et al., 
2006;Hughes et al. 2010;Lang et al.,2011c;Palestini et al.,2008;Roh et al.,2007;Moo et 
al.,2010;Rosenbaum et al.,2009) The higher rate of temporary hypoparathyroidism could be 
explained by the higher rate of unintentional removal of parathyroid glands (i.e. 
unintentional parathyroidectomy) and subsequent auto-transplantation.(Sywak et 
al.,2006;Hughes et al.,2010;Lang et al.,2011c) Unintentional devascularization of parathyroid 
glands during dissection also contributes to the higher rate of temporary 
hypoparathyroidism. In terms of temporary recurrent laryngeal nerve injury, Palestini et al. 
reported a higher rate of transient recurrent laryngeal nerve injury in patients undergoing 
thyroidectomy plus unilateral pCND (5.4% vs. 1.4%, p< 0.05) (Palestini et al.,2008) while 
other studies failed to show any statistically significant differences.(Sywak et al., 
2006;Hughes et al. 2010; Lang et al.,2011; Roh et al.,2007; Sadowski et al.2009;Rosenbaum et 
al.,2009) To date, no studies have shown an increase risk of permanent hypoparathyroidism 
or recurrent laryngeal nerve injury. A recent systematic review comprising 5 retrospective 
studies evaluated the morbidity of pCND and found that there was one extra case of 
transient hypocalcaemia for every eight pCND performed. (Chisholm et al.,2009) However, 
there was no increased risk of permanent hypocalcaemia, transient or permanent recurrent 
nerve injury.(Chisholm et al.,2009) 
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5. Conclusion 
Despite numerous reports on the various cervical and extra-cervical endoscopic approaches, 
the only truly minimally invasive approach in DTC appears to be MIVAT because it is 
associated with a shorter skin incision, minimal tissue dissection, shortened hospital stay, 
less wound infection and less pain. Unlike the cervical approaches, the extra-cervical 
approaches appear to have similar but not better outcomes than the open or conventional 
thyroidectomy and randomized trials comparing these approaches with open 
thyroidectomy are currently lacking.  However, the extra-cervical approaches remain a 
surgical option for patients who are motivated to remain “scarless in the neck”. The addition 
of da Vinci robot in endoscopic thyroidectomy (i.e. robotic-assisted thyroidectomy) may 
shorten operating time and increase the number of lymph nodes retrieved during 
thyroidectomy for DTC. Trans-oral thyroidectomy is technically feasible but remains 
experimental and appears to be associated with a higher rate of morbidity than the open 
approach. Surgical adjuncts such as IONM, IOPTH and alternate energy sources appear to 
be useful for surgeons to have as part of their armamentarium. Whether they actually 
improve surgical outcomes of patients over a standard open thyroidectomy remains to be 
determined by future prospective randomized studies. The role of pCND remains 
controversial as there is no good evidence to show that it improves long-term outcomes 
such as cancer-specific or disease-free survivals when compared to thyroidectomy without 
pCND. However, analysis of short-term markers for recurrence suggests that pCND may be 
associated with better short-term outcomes.  
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